FDA Inspection 873762 — Prescript Pharmaceuticals, Inc.

Prescript Pharmaceuticals, Inc. — FEI 1000135824

The FDA completed an inspection of Prescript Pharmaceuticals, Inc. on March 25, 2014 in Pleasanton, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 5 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 25, 2014
Fiscal Year
2014
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Pleasanton, CA (United States)

Citations

IDCFRDescription
127421 CFR 211.68(a)Calibration/Inspection/Checking not done
191421 CFR 211.166(a)Lack of written stability program
202621 CFR 211.192Quality control unit review of records
363021 CFR 211.170(b)Drug product reserve containers
439121 CFR 211.180(e)(2)Items to cover on annual reviews